论文部分内容阅读
2001年美国医药工业总产值占美国GDP的9.1％,当美国经济逆转,因“ 9.11”事件而出现衰退时,美国的药业经济仍然保持着8％～9％的高位增长。然而2001年美国药业市场的特点,却也明显地表现了恶性循环:在美国新药研发的资金投入越来越高,为弥补资金的不足,各大制药公司除加快资金的周转而扩大原有药品的生产,但仍还不如
In 2001, the U.S. pharmaceutical industry output accounted for 9.1% of U.S. GDP. While the U.S. economy was in the doldrums and the recession took place on September 11th, the U.S. pharmaceutical industry maintained a high growth rate of 8% -9%. However, the characteristics of the pharmaceutical market in the United States in 2001 clearly showed a vicious circle: in the United States, more and more funds are invested in research and development of new drugs. In order to make up for lack of funds, the major pharmaceutical companies have expanded their existing funds in addition to quickening the flow of funds Drug production, but still not as good